Li L - Search Results

1

Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study.

Li L, Zhou J, Li Y, Wang F, Zhang D, Wang M, Tao Y, Chen E. Li L, et al. Among authors: li y. Front Pharmacol. 2023 Jun 1;14:1165990. doi: 10.3389/fphar.2023.1165990. eCollection 2023. Front Pharmacol. 2023. PMID: 37324480 Free PMC article.

2

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.

Wang FD, Zhou J, Li LQ, Wang ML, Tao YC, Wang YH, Zhang DM, Chen EQ. Wang FD, et al. Front Microbiol. 2022 Jun 22;13:901233. doi: 10.3389/fmicb.2022.901233. eCollection 2022. Front Microbiol. 2022. PMID: 35814664 Free PMC article.

3

Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA.

Zhou J, Wang F, Li L, Chen E. Zhou J, et al. Among authors: li l. Precis Clin Med. 2022 Nov 29;5(4):pbac030. doi: 10.1093/pcmedi/pbac030. eCollection 2022 Dec. Precis Clin Med. 2022. PMID: 36519139 Free PMC article.

4

Management of in- and out-of-hospital screening for hepatitis C.

Zhou J, Wang FD, Li LQ, Chen EQ. Zhou J, et al. Front Public Health. 2023 Jan 25;10:984810. doi: 10.3389/fpubh.2022.984810. eCollection 2022. Front Public Health. 2023. PMID: 36761331 Free PMC article. Review.

5

Editorial: in the era of effective antiviral therapy, long-term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis.

Li LQ, Chen EQ. Li LQ, et al. Aliment Pharmacol Ther. 2023 Jun;57(12):1467-1468. doi: 10.1111/apt.17487. Aliment Pharmacol Ther. 2023. PMID: 37243456 No abstract available.

6

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir.

Da Wang F, Zhou J, Li LQ, Li YJ, Wang ML, Tao YC, Zhang DM, Wang YH, Chen EQ. Da Wang F, et al. Ann Hepatol. 2023 Sep-Oct;28(5):101119. doi: 10.1016/j.aohep.2023.101119. Epub 2023 Jun 2. Ann Hepatol. 2023. PMID: 37271480 Free article.

7

The urgency to expand the antiviral indications of general chronic hepatitis B patients.

Fan P, Li LQ, Chen EQ. Fan P, et al. Front Med (Lausanne). 2023 May 19;10:1165891. doi: 10.3389/fmed.2023.1165891. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37275355 Free PMC article. Review.

8

Fever of unknown origin and splenomegaly: a case report of visceral leishmaniasis diagnosed by metagenomic next-generation sequencing.

Li LQ, He Y, Liu T, Zhou J, Chen EQ. Li LQ, et al. Future Microbiol. 2023 Jul;18:699-705. doi: 10.2217/fmb-2023-0038. Epub 2023 Jul 31. Future Microbiol. 2023. PMID: 37522175

9

Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity.

Zhou J, Wang FD, Li LQ, Li YJ, Wang SY, Chen EQ. Zhou J, et al. J Clin Transl Hepatol. 2023 Dec 28;11(7):1465-1475. doi: 10.14218/JCTH.2023.00272. Epub 2023 Aug 25. J Clin Transl Hepatol. 2023. PMID: 38161505 Free PMC article.

10

Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence-Based Review on Emerging Clinical Data.

Li Y, Wang F, Zhou J, Li L, Song C, Chen E. Li Y, et al. Among authors: li l. Clin Pharmacol Ther. 2024 Aug;116(2):295-303. doi: 10.1002/cpt.3287. Epub 2024 Apr 30. Clin Pharmacol Ther. 2024. PMID: 38686952 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,981 results

Search Page

Filters